BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Germanò E, Italiano D, Lamberti M, Guerriero L, Privitera C, D'Amico G, Siracusano R, Ingrassia M, Spina E, Calabrò MP, Gagliano A. ECG parameters in children and adolescents treated with aripiprazole and risperidone. Prog Neuropsychopharmacol Biol Psychiatry 2014;51:23-7. [PMID: 24211841 DOI: 10.1016/j.pnpbp.2013.10.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Pillay J, Boylan K, Newton A, Hartling L, Vandermeer B, Nuspl M, MacGregor T, Featherstone R, Carrey N. Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update. Can J Psychiatry 2018;63:661-78. [PMID: 29865900 DOI: 10.1177/0706743718779950] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
2 Cicala G, Barbieri MA, Santoro V, Tata C, Colucci PV, Vanadia F, Drago F, Russo C, Cutroneo PM, Gagliano A, Spina E, Germanò E. Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study. Front Psychiatry 2020;11:152. [PMID: 32265749 DOI: 10.3389/fpsyt.2020.00152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Aronow WS, Shamliyan TA. Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders. Ann Transl Med 2018;6:147. [PMID: 29862236 DOI: 10.21037/atm.2018.03.17] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
4 Coustals N, Ménard ML, Cohen D. Aripiprazole in Children and Adolescents. J Child Adolesc Psychopharmacol 2021;31:4-32. [PMID: 32931315 DOI: 10.1089/cap.2020.0014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Jensen KG, Juul K, Fink-Jensen A, Correll CU, Pagsberg AK. Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials. J Am Acad Child Adolesc Psychiatry 2015;54:25-36. [PMID: 25524787 DOI: 10.1016/j.jaac.2014.10.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
6 Kirino E. Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents. Adolesc Health Med Ther 2014;5:211-21. [PMID: 25473324 DOI: 10.2147/AHMT.S50015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
7 Lamberti M, Siracusano R, Italiano D, Alosi N, Cucinotta F, Di Rosa G, Germanò E, Spina E, Gagliano A. Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study. Paediatr Drugs 2016;18:319-29. [PMID: 27278054 DOI: 10.1007/s40272-016-0183-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
8 Vo LC, Snyder C, McCracken C, McDougle CJ, McCracken JT, Aman MG, Tierney E, Arnold LE, Levi D, Kelleman M, Carroll D, Morrissey J, Vitiello B, Scahill L. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol 2016;26:900-8. [PMID: 27726426 DOI: 10.1089/cap.2016.0090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Palanca-maresca I, Ruiz-antorán B, Centeno-soto GA, Forti-buratti MA, Siles A, Usano A, Avendaño-solá C. Prevalence and Risk Factors of Prolonged Corrected QT Interval Among Children and Adolescents Treated With Antipsychotic Medications: A Long-Term Follow-Up in a Real-World Population. J Clin Psychopharmacol 2017;37:78-83. [DOI: 10.1097/jcp.0000000000000639] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
10 Kaguelidou F, Acquaviva E. Safety of Psychotropic Drugs in Children and Adolescents. In: Spina E, Trifirò G, editors. Pharmacovigilance in Psychiatry. Cham: Springer International Publishing; 2016. pp. 257-83. [DOI: 10.1007/978-3-319-24741-0_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Matera E, Margari L, Palmieri VO, Zagaria G, Palumbi R, Margari F. Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues. J Clin Psychopharmacol 2017;37:302-9. [DOI: 10.1097/jcp.0000000000000688] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Lamberti M, Italiano D, Guerriero L, D'Amico G, Siracusano R, Ingrassia M, Germanò E, Calabrò MP, Spina E, Gagliano A. Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder. Neuropsychiatr Dis Treat 2015;11:1169-74. [PMID: 26056451 DOI: 10.2147/NDT.S79866] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Jensen KG, Gärtner S, Correll CU, Rudå D, Klauber DG, Stentebjerg-Olesen M, Fagerlund B, Jepsen JR, Fink-Jensen A, Juul K, Pagsberg AK. Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial. Psychopharmacology (Berl) 2018;235:681-93. [PMID: 29185022 DOI: 10.1007/s00213-017-4784-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Hasnain M, Vieweg WV. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review. CNS Drugs. 2014;28:887-920. [PMID: 25168784 DOI: 10.1007/s40263-014-0196-9] [Cited by in Crossref: 92] [Cited by in F6Publishing: 73] [Article Influence: 13.1] [Reference Citation Analysis]
15 Pisano S, Catone G, Veltri S, Lanzara V, Pozzi M, Clementi E, Iuliano R, Riccio MP, Radice S, Molteni M, Capuano A, Gritti A, Coppola G, Milone A, Bravaccio C, Masi G. Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists. Ital J Pediatr 2016;42:51. [PMID: 27209326 DOI: 10.1186/s13052-016-0259-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
16 Karpuz D, Hallioglu O, Toros F, Tasdelen B. The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder. J Electrocardiol 2017;50:410-5. [PMID: 28274540 DOI: 10.1016/j.jelectrocard.2017.02.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]